ACC International Holdings Ltd. files SEC Form 4 disclosures for BRAINSTORM CELL THERAPEUTICS INC.. They have made 11 open-market trades across 1 company since 2011, most recently 2020-07-16.
CIK 0001521843
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
10 open-market purchases totalling $592K since 2011, against 1 sale. Across 10 scored buys the stock is up 3.1% at ninety days, and 2.9 points ahead of the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| BCLI | 135,306 | $160K |
Shares reported on the most recent Form 4, priced at the 2020-07-16 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -32.9% | +3.1% | +3.1% |
| Alpha | -27.1% | +2.9% | +2.9% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCLI | SELL | 2020-07-09 | 2020-07-16 | $13.39 | $961K | +7.5% | +3.6% | +20.2% |
| BCLI | BUY | 2015-10-01 | 2015-10-02 | $2.58 | $5K | -32.9% | +3.1% | +3.1% |
| BCLI | BUY | 2015-09-30 | 2015-10-01 | $2.34 | $22K | -32.9% | +3.1% | +3.1% |
| BCLI | BUY | 2014-10-10 | 2014-10-15 | $4.06 | $35K | -32.9% | +3.1% | +3.1% |
| BCLI | BUY | 2014-09-29 | 2014-10-01 | $4.14 | $28K | -32.9% | +3.1% | +3.1% |
| BCLI | BUY | 2014-09-19 | 2014-09-24 | $4.17 | $46K | -32.9% | +3.1% | +3.1% |
| BCLI | BUY | 2014-06-16 | 2014-06-20 | $0.29 | $38K | -32.9% | +3.1% | +3.1% |
| BCLI | BUY | 2014-06-13 | 2014-06-16 | $0.35 | $53K | -32.9% | +3.1% | +3.1% |
| BCLI | BUY | 2014-04-28 | 2014-05-02 | $0.30 | $282K | -32.9% | +3.1% | +3.1% |
| BCLI | BUY | 2011-06-16 | 2011-06-20 | $0.28 | $28K | -32.9% | +3.1% | +3.1% |
| BCLI | BUY | 2011-05-18 | 2011-06-15 | $0.29 | $57K | -32.9% | +3.1% | +3.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.